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Background. The past few years have seen a vast increase in the amount of genomic data available for a growing number of
taxa, including sets of full length cDNA clones and cis-regulatory sequences. Large scale cross-species comparisons of protein
function and cis-regulatory sequences may help to understand the emergence of specific traits during evolution. Principal
Findings. To facilitate such comparisons, we developed a Gateway compatible vector set, which can be used to systematically
dissect cis-regulatory sequences, and overexpress wild type or tagged proteins in a variety of chordate systems. It was
developed and first characterised in the embryos of the ascidian Ciona intestinalis, in which large scale analyses are easier to
perform than in vertebrates, owing to the very efficient embryo electroporation protocol available in this organism. Its use was
then extended to fish embryos and cultured mammalian cells. Conclusion. This versatile vector set opens the way to the mid-
to large-scale comparative analyses of protein function and cis-regulatory sequences across chordate evolution. A complete
user manual is provided as supplemental material.
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Analyses in Ciona and Vertebrate Embryos. PLoS ONE 2(9): e916. doi:10.1371/journal.pone.0000916
INTRODUCTION
The massive increase in sequence and annotation data that can be
collected over a short term on any given organism has had major
consequences in developmental and evolutionary studies. Besides
its impact on classical metazoan model organisms such as mouse,
Drosophila or C. elegans, the genomic revolution also led to the
emergence of novel model organisms with interesting phylogenetic
positions, and to the molecular revival of classical model organisms
that had long been neglected, such as the ascidians. Comparison of
the large sets of genomic data in this growing range of species may
help understand the emergence of specific traits during evolution.
Because of the importance of Gene Regulatory Networks in the
generation of organismal complexity [1], the assessment of the
level of cis-regulatory sequence activity and protein function
during metazoan evolution can be particularly insightful [2,3].
The chordate phylum groups cephalochordates, tunicates and
vertebrates, which share a tadpole-like larval body plan thought to
be inherited from their last common ancestor. It is, however,
currently unclear to what extent this shared body plan is underlain
by common gene regulatory networks. For example, although the
tunicates, including the ascidian Ciona intestinalis, are thought to be
the closest relative to the vertebrates [4], their embryos have
a peculiar mode of development based on the existence of a fixed
lineage [5]. Further, orthologous ascidian and vertebrate tran-
scription factors can diverge in their activity [6]. Finally, ascidian
and vertebrate genomes show poor synteny and little if any
conservation of non-coding sequences [7,8]. Systematic compar-
ison of the activity of ascidian and vertebrate regulatory sequences
and protein function may thus help define the extent of
conservation in the various chordate developmental GRNs that
ultimately lead to the establishment of the same larval body plan.
In this article, we present a set of versatile expression vectors
that can be used to systematically compare the activity of proteins
and cis-regulatory sequences across the chordate phylum. This
vector set is based on the Gateway site-specific recombination
cloning technology which allows mid- to high-throughput cloning
[9]. In this system entry clones that contain a fragment of DNA of
interest flanked by specific attL feet are first generated. Each entry
clone can then be recombined with a variety of custom destination
vectors that include a selection cassette flanked by attR feet. The
resulting expression vectors contain the DNA of interest flanked by
attB feet, which are short and expected to interfere minimally with
the biological activity of the cloned fragment [10–12] . Recent
progress provided an expanded collection of recombination sites
with distinct specificities, leading to Multisite Gateway technology
in which more than one entry clone can be recombined into
a destination vector [13]. Multisite Gateway technology has in
particular been adapted in the nematode community to make full
use of the large sets of promoters (promoterome, [14] ) and
predicted Open Reading Frames (ORFeome; [15]) generated in
this community. None of these vector systems has however been
tested and shown to work in a range of organisms.
The vector set presented here (See Fig. 1 for a general overview)
is a general platform which can be used to precisely dissect cis-
regulatory sequences, and to overexpress wild type or tagged
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PLoS ONE | www.plosone.org 1 September 2007 | Issue 9 | e916proteins in a variety of chordate systems. It was developed and first
characterised in the embryos of the ascidian Ciona intestinalis,i n
which large scale analyses are easier to perform than in
vertebrates, owing to the very efficient embryo electroporation
protocol available in this organism [16]. We then showed that the
use of these vectors can be extended to both fish embryos and
cultured mammalian cell lines. This study thus opens the way for
the mid- to large-scale comparative analysis of protein function
and cis-regulatory sequences within chordates.
RESULTS
Introduction of an RfA cassette into a set of
transgenesis vectors
We first adapted the pSP72-1.27 transgenesis vector initially
developed for C. elegans [17] and also known to be efficient in
ascidians [16]. A new polylinker was first inserted between the
BamH1 and EcoR1 sites of pSP72-1.27, giving rise to
pSP72BSSPE (Fig. 1A, material and methods). This polylinker
can be used to clone a Gateway cassette (Pme1), N-terminal (Stu1)
or C-terminal (EcoRV) tags and a driver (Swa1).
As in most Gateway cDNA libraries, including available Ciona
Gateway cDNA libraries, the cDNA inserts are placed between
attL1 and L2 recombination sites, we used an attR1/R2
destination cassette compatible with these inserts. Three types of
attR1/R2 cassettes, RfA, RfB and RfC, exist differing in the
reading frame to be used when designing the entry clones to
respect the frame of the N- and C-terminal tags. To enforce
compatibility between entry clones generated by the various
laboratories of a scientific community, all our vectors make use of
the RfA cassette, which is compatible with the Invitrogen Gateway
bacterial expression vectors and Proquest Yeast 2 hybrid system
(pDest22 and 32 vectors). Thus, the ORF entry clones used for in
vivo tests with this vector set can be used for additional
characterisation of the function of proteins of interest.
Functional analysis of a cDNA of interest includes the
determination of its subcellular localisation by overexpression of
a fluorescently tagged protein. For this, we introduced an N-
terminal tag preceded by a Kozak sequence, or a C-terminal tag
followed by a Stop codon in the Stu1 and EcoRV sites,
respectively, placed on either side of the cassette. The current
vector set includes N- and C-terminal Venus YFP and HA tags as
well as C-terminal CFP (Fig. 1A).
To test the functionality of these vectors, the Ci-FOG (Ciona
Friend Of Gata) cis-regulatory sequences, driving expression in all
Ciona animal blastomeres between the 16-cell and early gastrula
stages [18], was cloned into the Swa1 site of several vectors of the
pSP72BSSPE swa1::RfA series, giving rise to the pSP72BSSPE-
pFOG::RfA series of destination vectors (Fig. 2A). We next
generated a collection of entry clones for a set of ORFs of interest
Figure 1. Overview of the vectors described in this article.
doi:10.1371/journal.pone.0000916.g001
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including the nucleus, plasma membrane, basolateral membranes,
whole microtubule network and centrosomes (Figure 2B). A
detailed procedure for generating ORF entry clones can be found
on page 11 of the accompanying Chordate Gateway vector
manual (Manual S1).
These entry clones were recombined with pSP72BSSPE-
pFOG::RfA destination vectors (Fig 2A) and the resulting
expression clone were electroporated into fertilised ascidian eggs.
Overexpression of these proteins had no effect on embryo viability.
Fig. 2B recapitulates the observed subcellular localisation of the
produced fluorescent protein. Fig. 3 illustrates some of the results
obtained. At the early gastrula stage, pSP72-pFOG::B1-GAP43-
GFP-B2 targeted GFP expression to the cell membrane of animal
cells (Fig. 3A) [19,20]. pSP72-pFOG::B1-Kozak-Histone2B-B2–
Venus decorated the animal nuclei (Fig. 3B). pSP72-pFOG::B1-
Ensconsin-3GFP-B2 marked the whole microtubule network
(Fig. 3C). Interestingly, localisation of the venus-tagged single
Ciona Aurora kinase, Ci-Aur (Fig. 3E), driven by pSP72-
pFOG::B1-aurora-B2-Venus recapitulated the cellular localisation
of the two well-studied vertebrate aurora kinases Aurora A and
Aurora B during mitosis. In prophase, Ci-Aur was found, like
vertebrate Aurora A, around the centrosomes and, like Aurora B,
in a punctate staining in the nucleus, which likely corresponds to
a chromosomal centromeric staining. During metaphase, Ci-Aur-
Venus strongly localised to the centrosome and uniformly on the
mitotic spindle. In anaphase and telophase, the spindle staining
concentrated around the spindle midzone, like vertebrate Aurora
B [21] .During cytokinesis, spindle midzone/midbody staining
increased, whereas centrosomal staining disappeared.
Taken together, these results indicate that the introduction of
the polylinker and Gateway cassette into the pSP72 vectors does
not significantly interferes with the subcellular localisation of the
expressed proteins. Likewise, the expected animal restriction of the
domain of expression of the fluorescent proteins, suggests that the
introduction of the attR1/R2 Gateway recombination sequences
does not alter the activity of the cis-regulatory regions used as
drivers. The suitability of the pSP72BSSPE-Swa1::RfA series of
transgenesis vectors to drive expression of functional transcription
factors or signalling ligands of interest under control of various cis-
regulatory regions was further recently reported [18,22].
Finally, co-electroporation of pSP72-pFOG::B1-Kozak-GATAa-
B2-HA and pSP72-pFOG::Venus-B1-GATAa-Stop-B2, and immu-
nodetection with antibodies against HA or GFP respectively,
illustrates that co-electroporation of two similar vectors is an efficient
way to co-express several proteins in the same cells (Fig. 3F, G).
Design of 2-cassette transgenesis vectors in which
both cis-regulatory sequences and ORFs can be
Gateway cloned
Although the transgenesis vectors presented in the first section offer
significant improvement over the parental pSP72 series, the cis-
regulatory regions still need to be conventionally cloned precluding
the scaling up of regulatory sequence analyses. We next transformed
these vectors to allow Gateway cloning of both cis-regulatory
sequences and ORF of interest. Previous work indicated that
flanking a cis-regulatory region with attB1 and attB2 recombination
feet does not interfere with its activity in E. coli, insect (Sf9 line), or
mammalian cells [9], a feature we confirmed in ascidians [22].
However, because attB1 and attB2 recombination sites were already
used to clone the ORFs in our vectors, and because no suitable
cassette was available, we developed a novel Gateway R3-ccdB-
CmR-R5 cassette (see below) to receive cis-regulatory regions, and
inserted it into the Xho1-Xba1 sites upstream the BamH1 site of
vectors of the pSP72BSSPE swa1:: RfA series described in the
previous section (Fig. 1B). This cassette recombines with pEntr-L3-
cis-reg-L5 entry clones containing cis-regulatory regions.
To create the novel Donor/Destination system based on the
attB3-B5 recombination sites we first constructed the pDONR-
221-P3/P5 donor vector (Fig. 4A). For this, point mutations were
introduced into the 7 nucleotides of the attP1 and attP2
recombination sites of pDONR-221 that confer the specificity of
the recombination (Fig. 4B) [23]. The resulting vector was tested
by amplifying the pFOG regulatory region and flanking them with
attB3 and attB5 recombination sequences. Recombination in a BP
reaction of this 2 kb fragment in pDONR-221-P3/P5, followed by
transformation into electrocompetent DH5alpha bacteria pro-
duced several hundred colonies (Table 1). Sequence analysis of 13
colonies revealed that the recombination was correct in all tested
colonies. Additional cloning of the muscle-specific Ci-Sna cis-
regulatory region (pSna; [24] ) confirmed the high efficiency of BP
cloning into this new donor vector (not shown).
The destination R3-ccdB-CmR-R5 destination cassette was
generated from this donor vector by orienting the Gateway BP
reaction, which generates both an attL-flanked entry construct and
an attR-flanked destination cassette, so that the destination cassette
is the cloned product of the recombination [23].
To test the functionality of this cassette, it was cloned between
the Xho1 and Xba1 sites of pSP72 swa1::B1-GATAa-B2-Venus
and pSP72 swa1::B1-Kozak-NLS-LacZ-stop-B2, thus giving rise
to the pSP72-R3-ccdB-CmR-R5::B1-Kozak-GATAa-B2-Venus
Figure 2. Destination vectors and ORF entry clones used to test the
pSP72-swa1::RfA vector series. A) Destination vectors for the over-
expresion of WT or tagged ORFs under the control of the animal-
specific cis-regulatory regions of Ciona Friend of GATA (Ci-FOG). B)
Generated ORF entry clones with the obeserved subcellular localisation
of the corresponding tagged proteins.
doi:10.1371/journal.pone.0000916.g002
Chordate Gateway vectors
PLoS ONE | www.plosone.org 3 September 2007 | Issue 9 | e916pSP72-R3-R5::B1-Kozak-NLS-LacZ-stop-B2 destination vectors.
The efficiency of LR recombination of cis-regulatory sequences
into these new vectors, as schematised on Fig. 5A, was assayed by
recombination with the pENTR-attL3-pFOG-attL5 entry clone
obtained above. The number of ampicillin-resistant colonies
obtained was comparable to what is typically obtained with the
R1-R2 system (Table 1). Following transformation into bacteria, 3
to 5 colonies were analysed by restriction digest and sequencing,
Figure 3. Subcellular localisation of tagged proteins expressed from pSP72-pFOG::RfA vector series. A, B, F, G epifluorescence pictures of embryos
expressing GAP-43 venus (A), Histone2B-venus (B), venus-GATAa (F) and GATAa-HA (G). F and G show the same embryo co-electroporated with
pSP72-pFOG::Venus-B1-GATAa-B2 and pSP72-pFOG::B1-GATAa-B2-HA. C, D, E projections of confocal stacks of images from embryos either
electroporated (C, E) or microinjected with mRNA (D) and expressing ensconsin-3GFP (C, D), or ci-aurora kinase (E). Due to the mosaic expression of
the transgene, some cells express the marker at a lower level (C, F, G).
doi:10.1371/journal.pone.0000916.g003
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specificity of the attR3-R5 recombination, an LR reaction was
performed between the same amount of pENTR-attL3-pFOG-
attL5 and an RfA (attR1/R2) destination vector. Following
transformation into bacteria, no ampicillin-resistant colony were
obtained, indicating that attR3-R5 recombination is hihgly specific
as attL3/L5 entry clones recombine into attR1/R2 destination
cassettes at least two orders of magnitude less efficiently than into
attR3/R5 cassettes (not shown). Similarly, recombination of an
attL1-L2 entry clone into a vector bearing an R3-R5 cassette was
very inefficient (not shown).
We next tested whether introduction of the exogenous attB3/B5
feet interfered with the activity of the cloned driver. We
electroporated in parallel pSP72-B3-pFOG-B5::B1-Kozak-GA-
TAa-B2-Venus and pSP72-pFOG::B1-Kozak-GATAa-B2-Venus
in which the cis-regulatory sequences of pFOG was inserted by
standard restriction enzyme-mediated cloning. The results
obtained with these two vectors were indistinguishable both in
terms of the identity of the cells expressing the fluorescently tagged
GATAa protein, and of the level of expression of the protein
(Fig. 5B, C). Identical results were also obtained when comparing
Xgal staining in parallel electroporations of pSP72-pFOG::NLS-
lacZ with pSP72-B3-pFOG-B5::B1-Kozak-NLS-lacZ-stop-B2
(Fig. 5D, E). Likewise, electroporation of pSP72-B3-pSna-
B5::B1-Kozak-NLS-lacZ-stop-B2 led to the expected muscle
specific X-gal staining (Fig. 5F), further indicating that combina-
Figure 4. Donor vectors of different recombination specificities. A) list of generated vectors with the identity of the recombination sites and type of
element cloned. B) Sequence of the recombination sites used in the different donor vectors.
doi:10.1371/journal.pone.0000916.g004
Table 1. REACTION EFFICIENCY AND SPECIFICITY
..................................................................................................................................................
BP Reaction (attB PCR product X pDonor)
Nber Bacterial
colonies*
Nber of Colonies
analysed
Accurately recombined
clones
Percentage of correct
pEntry
B1-kozak-Venus-stop-B2 X pDONR 221 .1000 3 3 100%
B3-pFOG-B5 X pDONR P3-P5 .300 13 13 100%
B3-a-element-B4 X pDONR P3-P4 .1000 3 3 100%
B4R-bpFOG-B5 X pDONR P4R-P5 .500 20 2 10%
LR reaction (pEntry X pDestination) Nber Bacterial
colonies *
Nber of Colonies
analysed
Accurately recombined
clones
Percentage of correct
Expression clones
pENTR attL1-kozak-Venus-stop-L2 X pSP72-pFOG-RfA .1000 5 5 100%
pENTR attL3-pFOG-attL5 X pSP72-R3-R5::B1-kozak-NLS-LacZ-stop-B2 .500 3 3 100%
pENTR attL3-pFOG-attL5 X pSP72-R3-R5::R1-kozak-GATAa-R2-Venus .150 5 5 100%
pENTR attL3-pFOG-attL5+pENTR attL1-kozak-GATAa-attL2 X pSP72-
R3-R5::RfA-Venus
,20 5 4 80%
pENTR-L3-a-element-L4+pENTR-R4-bpFOG-L5 X pSP72-R3-R5:: B1-
kozak-GATAa-B2-Venus
,20 4 4 100%
pENTR-L3-a-element-L4+pENTR-R4-bpFOG-L5 X pSP72-R3-R5::B1-
kozak-NLS-LacZ-stop-B2
,20 4 3 75%
*Nber of colonies obtained by plating the whole recombination reaction following electrotransformation into DH5a bacteria (.10
8 col/mg)
X: means recombination between attB PCR product and pDonor or pEntry and pDestination.
doi:10.1371/journal.pone.0000916.t001
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transgenic constructs in ascidian embryos.
The attR3/R5 recombination cassette thus provides an
alternative to the classical attR1/R2 Gateway system in terms of
specificity of recombination, and lack of interference with the
transcriptional activity of cloned drivers.
Simultaneous introduction of a cis-regulatory region
and an ORF of interest in a 2-cassette destination
vector
We next wanted to test whether simultaneous recombination of
a cis-regulatory region and ORF could be achieved (Fig. 6).
Figure 5. Cloning of cis-regulatory sequences in the R3-R5 cassette. A) scheme of the recombination of an L3-cis-reg-L5 entry clone into the R3-R5
cassette of a destination vector. B-F) Activity of the indicated constructs introduced in embryos by electroporation. B, C) The reporter was GATAa-
venus. D-F) The reporter was NLS-LacZ.
doi:10.1371/journal.pone.0000916.g005
Chordate Gateway vectors
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Xho1-Xba1 sites of pSP72-Swa::RfA-Venus, giving rise to the
pSP72-R3-ccdB-CmR-R5::RfA-Venus two-cassette destination
vector (Fig. 1B). We then simultaneously LR recombined into
this destination vector the pENTR attL3-pFOG-attL5 cis-
regulatory entry clone and the pENTR attL1-Kozak-GATAa-
attL2 ORF entry clone (Fig. 2). Electro-transformation into DH5a
bacteria gave rise to one order of magnitude fewer colonies than
the recombination of a single attL3-L5 or attL1-L2 entry clone
(Table 1). Analysis by restriction enzyme digestion of 5 colonies,
revealed that 4 of these colonies contained a plasmid of expected
structure, demonstrating a recombination specificity of 80%
similar to the specificity obtained with a single recombination
involving either R1/R2 or R3/R5. Electroporation of the
resulting plasmids confirmed the functionality of the recombined
vectors (Fig. 6B, C).
Encouraged by these results, we introduced the R3-R5 cassette
into the Xho1-Xba1 sites of several electroporation destination
vectors for analysisofuntagged,C-terminally orN-terminally tagged
proteins under control of cis-regulatory regions of interest (Fig. 1B).
Replacement of a single segment in a pSP72-B3-cis-
reg-B5::B1-ORF-B2 expression clone
While the presence of the two cassettes greatly enhances the
flexibility of the vector system, simultaneous recombination of two
cassettes into a destination vector, which is less efficient than
simple recombination, is often not necessary. For instance,
scientists interested in analysing the activity of cis-regulatory
sequences may simply want to recombine various genomic
fragments into a destination vector that places them in front of
a suitable reporter gene. Conversely, a laboratory interested in the
formation of a given tissue, may want to place a variety of ORFs
under control of a driver specific for this tissue. In this section, we
show that starting from a pSP72-B3-cis-reg-B5::B1-ORF-B2
expression clone, it is possible to free either the attR3/R5 or the
RfA cassette from the expression clone, thus giving rise to pSP72-
R3-ccdB-CmR-R5::B1-ORF-B2 or pSP72-B3-cis-reg-B5::RfA sin-
gle-cassette destination vectors.
To exemplify the process, we started from the pSP72-B3-
pFOG-B5:: B1-Kozak-GATAa-B2-venus expression clone. Two
BP reactions were set between the expression clone and either an
Figure 6. Simultaneous introduction of a cis-regulatory region in the R3-R5 cassette and an ORF in the RfA cassette. A) Experimental scheme. B)
Comparison of the activity by electroporation of the indicated constructs. The weaker fluorescence observed in C is not representative. Due to mosaic
expression of the transgene, only some cells express the fluorescent marker.
doi:10.1371/journal.pone.0000916.g006
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the corresponding donor vector (see materials and methods).
Following transformation into ccdB-resistant DB3.1 cells, trans-
formants were selected on Ampicillin+Chloramphenicol plates to
isolate pSP72-B3-pFOG-B5::RfA-Venus and pSP72-R3-ccdB-
CmR-R5::B1-Kozak-GATAa-B2-Venus. The efficiencies of these
reactions were comparable to that of the introduction of an entry
clone into the attR1-ccdB-CmR-attR2 destination cassette. In the
case of pSP72-B3-pFOG-B5::RfA-Venus, 4 out of 5 colonies
analysed by restriction enzyme digest had the expected structure
and could recombine with a different attL1/L2 entry clone (not
shown). A similar efficiency and specificity was obtained for
pSP72-R3-ccdB-CmR-R5::B1-GATAa-B2-Venus.
This strategy can be generally applied and these intermediate
destination vectors can constitute tools of general interest. For
instance, the pSP72-R3-ccdB-CmR-R5::B1-Kozak-NLS-LacZ-
Stop-B1 vector of the current release allows to clone cis-regulatory
sequences in front of NLS-lacZ reporter.
Independent analysis of basal promoters and distal
cis-regulatory modules using a Multisite Gateway
strategy
Cis-regulatory sequences are commonly composed of basal
promoters located close to the start of transcription, and tissue-
specific enhancers or silencers located at a distance. Analysis of
a cis-regulatory logic requires that these two types of modules be
analysed, and hence cloned, separately. We thus adapted the
Gateway Multisite technology [13] to independently recombine
two entry clones, one carrying a basal promoter, the other a distal
element, into the attR3/R5 destination cassette of our vector set
(Fig. 8A). For this, we manipulated the attP1 and P2 re-
combination sites to create two new donor vectors, pDONR-
221-P3/P4, used to clone the distal element, and pDONR-221-
P4R/P5, used to clone the basal promoter (see materials and
methods) (Fig. 4A, B).
To test the pDONR-221-P3/P4 vector, we amplified by PCR
and flanked with attB3 and B4 sites the early neural element of the
Ciona intestinalis Ci-Otx gene (a-element, [25] (see materials and
methods and Manual S1 page 16 for the design and sequence of
the PCR primers). BP recombination of this fragment with
pDONR-221-P3/P4, followed by transformation gave rise to
a similar number of colonies as a classical B1-B2 recombination
into pDONR-221 (Table 1). 3 colonies were picked at random and
analysed by restriction digest and sequencing. All 3 had the
structure expected for pENTR-L3-a-element-L4. Entry clones for
the early notochord eBra enhancer ( [16]; pENTR-L3-eBra-L4)
and the endodermal enhancer of Ci-Titf1 ( [26]; pENTR-L3-Ci-
Titf-L4) were similarly generated.
To test the pDONR-221-P4R/P5 vector, we PCR amplified the
basal promoter of the FOG gene (bpFOG; [22] ), and flanked it
with attB4R and attB5 sequences. This fragment was BP
recombined into pDONR221-P4R/P5. The efficiency of this
reaction, as measured by the number of kanamycin-resistant
colonies obtained, was high (Table 1). Restriction enzyme digest
analysis revealed, however, the presence of two populations of
plasmids. Plasmids from 2 out of 20 colonies analysed showed the
restriction digest profile expected for pENTR-attR4-bpFOG-L5.
Figure 7. Strategy for the replacement of a cis-regulatory (A) or ORF ((B) segment by the corresponding Gateway cassette.
doi:10.1371/journal.pone.0000916.g007
Chordate Gateway vectors
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specificity is not a serious problem. As the number of colonies
obtained is not limiting, PCR selection of the correctly recombined
versus empty clones is simple, and the number of basal promoters
routinely used to characterise the activity of distal elements
limited. Yet, we wanted to further understand why a large
proportion of recombined clones had undergone an illegitimate
recombination. We thought that the sequence homologies between
attP4R and attP5 may allow recombination between these attP
sites. To test this hypothesis, we set up a BP recombination
reaction with pDonor-attP4R/P5 alone, in absence of any
attB4R/B5 PCR product. The result of this reaction was
transformed into DH5a and plated onto Kanamycin plates. A
high number of clones was obtained and sequence analysis
Figure 8. Simultaneous introduction of an enhancer and basal promoter into a destination vector. A) Experimental scheme. B-F) Results of the
electroporation of the indicated constructs generated by conventional cloning (B, D) or by Gateway cloning (C, E, F). The numbers indicate the
proportion of embryos with the shown lacZ staining.
doi:10.1371/journal.pone.0000916.g008
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attP5, resulting in a loss of the ccdB and chloramphenicol
resistance genes.
We next simultaneously recombined pENTR-L3-a-element-L4
and pENTR-R4-bpFOG-L5 into the attR3/R5 Gateway cassette
of either pSP72-R3-ccdB-CmR-R5::B1-GATAa-stop-B2-Venus
or pSP72-R3-ccdB-CmR-R5::B1-Kozak-NLS-LacZ-stop-B2, ac-
cording to the scheme presented Fig. 8A. 10 femtomoles of each
plasmid were incubated with the LR Plus clonase mix and the
result transformed into electrocompetent DH5a bacteria (2.2 10
8
colonies/mg of plasmid DNA). The results presented in Table 1
demonstrated that while only few colonies were obtained, over
80% of these colonies harboured a plasmid of expected structure.
In many cases, simultaneous recombination of a minimal
promoter and an enhancer is however not necessary, most
enhancers being tested in the context of a very small number of
minimal promoters.
By inverting as previously the BP reaction between the P3-
ccdB/CmR-P4-DONR cassette and the pSP72-B3-a-element-B4-
bpFOG-B5-B1-Kozak-NLS-LacZ-stop-B2 expression clone, we
generated the pSP72-R3-ccdB-CmR-R4-bpFOG-B5::B1-Kozak-
NLS-LacZ-stop-B2 destination vector. This construct is useful to
test enhancer sequences and is included in the current vector
collection release. Functionality of this vector was further
demonstrated by recombining it with the pENTR-L3-eBra-L4
and pENTR-L3-Ci-Titf-L4 enhancer clones constructs.
Finally, we tested whether the insertion of attB3, B4 and B5
interfered with the activity of the cloned regulatory sequences. The
three expression clones pSP72-B3-a-element-B4-bpFOG-B5::B1-
NLS-LacZ-B2, pSP72-B3-eBra-B4-bpFOG-B5::B1-NLS-LacZ-B2,
and pSP72-B3-Ci-Titf-B4-bpFOG-B5::B1-NLS-LacZ-B2 were elec-
troporated into fertilised eggs and their activity measured by Xgal
staining at the 110-cell (a-element, eBra) and mid-gastrula (Ci-Titf)
stages. The presence of X-gal positive cells was in all cases restricted
to the expected tissues, induced neural precursors for the a element,
notochord for eBra and endoderm for Ci-Titf, establishing that the
attBs do not alter the spatial activity of the enhancers (Fig. 8 C, E,F).
To test whether attBs altered the level of activity of the
enhancers, we electroporated in parallel a construct generated via
Gateway technology (pSP72-B3-a-element-B4-bpFOG-B5::B1-
NLS-LacZ-B2, pSP72-B3-eBra-B4-bpFOG-B5::B1-NLS-LacZ-B2)
and the corresponding construct generated by conventional re-
striction enzyme cloning (pSP72-a-element-bpFOG::NLS-LacZ,
pSP72-eBra-bpFOG::NLS-LacZ). Analysis of LacZ activity at the
110-cellstagebyX-galstainingrevealedasimilarlevelofactivity,the
presence of the attB sequences leading to a 15-20% lower level of
expression unlikely to interfere with most applications (Fig 8 B-E).
Taken together these experiments demonstrate that the B3-B4-
B5 Multisite Gateway strategy allows to simultaneously or
sequentially clone an enhancer and a basal promoter into pSP72
R3-R5::B1-ORF-B2 destination vectors and that the presence of
attB sequences does not significantly affect the activity of these
elements.
Generation of a set of vectors to produce synthetic
mRNAs for microinjections
Microinjection of synthetic mRNAs is an alternative route to
overexpress proteins in chordate embryos. To generate a set of
synthetic mRNA vectors compatible with the same entry clones as
the electroporation vectors, we adapted the pRN3 synthetic mRNA
vector, initially developed for Xenopus studies [27] and used in
ascidian [25], urchin [28] and zebrafish embryos [29]. A novel
polylinker was introduced between the EcoR1 and Not1 sites of
pRN3 and used to clone the RfA Gateway cassette (Pme1) and
flanking N- (Stu 1) or C-terminal (Eco RV) fusion tags (Fig. 1C).
These mRNA vectors were designed to be compatible with the ORF
entry clones generated for the electroporation vectors.
To test the functionality of the vectors, we recombined pEntr-
L1-Kozak-Ensconsin-3GFP-Stop-L2 into pSPE3-RfA to give rise
to expression clones, which were used to synthesize mRNA in vitro.
Fig. 3D illustrates that the resulting mRNA, when injected into
ascidian eggs efficiently drives production of a protein, which
localises as expected to the microtubule network.
Use in vertebrate embryos and cells
Finally, we tested whether the Gateway transgenesis vectors would
also be suitable for use in vertebrate systems.
To test whether the pSP72-R3-R5::RfA vectors were suitable to
monitor enhancer activity in mammalian tissue culture, we first
constructed a Gateway entry clone containing the strong
ubiquitous CMV enhancer in front of the tk promoter (pENTR-
attL3-CMV-tk-attL5), LR recombined it into pSP72-R3-ccdB-
CmR-R5::B1-Kozak-NLS-LacZ-Stop-B2. The activity of this
construct in HeLa carcinoma cells was very similar to that of
pCMV-LacZ, obtained by classical restriction enzyme-mediated
cloning (Fig. 9A, left-most two columns). Next, we tested whether
the Gateway system interfered with tissue specific expression.
Three entry clones were generated containing the minimal tk
promoter (pENTR-attL3-tk-attL5) [30], the murine p63 C15
enhancer [31] in front of the tk promoter (pENTR-attL3-C15-tk-
attL5), the murine p63 C40 enhancer [31] in front of the tk
minimal promoter (pENTR-attL3-C40-tk-attL5) and the murine
p63 C50 enhancer placed in front of the tk promoter (pENTR-
attL3-C50-tk-attL5). C15 and C40 were previously reported to be
keratinocyte-specific [31], while C50 is a strong ubiquitous
enhancer (Dario Antonini and CM, unpublished). Expression
constructs, generated by LR recombination of the resulting entry
clones into pSP72-R3-ccdB-CmR-R5::B1-Kozak-NLS-LacZ-
Stop-B2, were transfected into HeLa cells or into HaCaT
keratinocytes and the number of LacZ positive cells analysed
(Fig. 9A). pSP72-B3-tk-B5::B1-Kozak-NLS-LacZ-Stop-B2 had
a very low level of activity in both cell lines in keeping with the
idea that no exogenous enhancer was present in the vector
backbone. pSP72-B3-C50-tk-B5::B1-Kozak-NLS-LacZ-Stop-B2
drove a strong expression of the reporter in both cell lines, as
expected. The activity of pSP72-B3-C15-tk-B5::B1-Kozak-NLS-
LacZ-Stop-B2 and pSP72-B3-C40-tk-B5::B1-Kozak-NLS-LacZ-
Stop-B2 was weaker than that of the C50 construct and restricted
to the keratinocytes as expected.
To further assess that the vector backbone and Gateway
recombination sequences did not interfere with the activity of
vertebrate cis-regulatory regions, the 2.4kb zebrafish shh upstream
cis-regulatory region, driving expression in the anterior floor plate
of fish embryos [32,33] were amplified with flanking attB3-B5 feet
and recombined into pDONR-221-P3/P5. The resulting entry
clone was jointly recombined with pENTR-L1-Kozak-Venus-
Stop-L2 into pSP72-R3-ccdB-CmR-R5::RfA to generate pSP72-
B3-zf-2.4shh-B5::B1-Kozak-Venus-Stop-B2. This construct was
microinjected into zebrafish fertilised eggs (Fig. 9B) alongside
a similar construct (pCS2+-shh2.4::gfp) (Fig. 9C) in a commonly
used fish transgenesis vector lacking the Gateway recombination
sequences, pCS2+ [32]. The distribution and number of
transiently transfected fluorescent cells and the number of
expressing embryos at 1 day post-fertilisation was indistinguishable
with the two vectors (pCS2+-2.4shh:GFP: 56,7% of injected
embryos were expressing the GFP; pSP72-B3-zf-2.4shh-B5::B1-
Kozak-Venus-Stop-B2: 52,3% showed YFP-expression (Fig. 9B,
Chordate Gateway vectors
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with pSP72-B3-zf-2.4shh-B5::B1-Kozak-NLS-LacZ-Stop-B2 was
similar to that obtained with the fluorescent reporter (32,7% of
injected embryos showed lacZ-positive cells) (Fig. 9 D). The vector
set described in this article can thus be used throughout the
chordate phylum.
DISCUSSION
In this article, we presented a collection of Gateway vectors,
initially developed for Ciona embryos, but also functional in
zebrafish embryos, and mammalian cells in culture. The collection
includes two types of vectors, compatible with the same collection
of ORF entry clones. The pSPE3 series allows to synthesize in vitro
mRNA for wild type or tagged proteins of interest. The pSP72
series of transgenesis/electroporation vectors allows to simulta-
neously recombine a cis-regulatory region and an ORF of interest
into a two-cassette vector. Further, we showed that a cloned
fragment of cis-regulatory or ORF DNA can be remobilised to
generate a novel destination vector, which can in turn be used to
recombine one or two new DNA segments. Although several other
Gateway eukaryotic expression vector sets have been reported in
the literature, designed for C. elegans [10], Drosophila (http://www.
ciwemb.edu/labs/murphy/Gateway%20vectors.html), plants
[34,35] or mammalian cells [12] our vector set represents to our
knowledge the only vector set that allows to test the activity of
complex cis-regulatory sequences, enhancers, promoters as well as
the function and subcellular localisation of the product of ORFs.
These vectors, as well as a collection of entry clones for Ciona cis-
regulatory regions and fluorescent reporters for major sub-cellular
organelles, are released to the community as a 96 well-plate stock,
accompanied with a complete user manual.
In this discussion, we highlight the flexibility of the system and
present its foreseeable applications to the systems biology of
chordate embryonic development.
Gateway recombination feet do not interfere with
protein or cis-regulatory activity
The aim of this work was to generate a versatile vector suite
allowing the mid- to high-throughput analysis of cis-regulatory
sequences and protein function. We chose to adopt the Gateway
system to bypass the limitations of restriction enzyme mediated
cloning. In particular, restriction enzyme mediated cloning of an
insert requires that the cloning enzymes do not cut within the
insert. This cloning strategy is insert-dependent, precluding
systematic cloning approaches. In contrast, the Gateway system
provides an insert-independent cloning strategy [36]. A possible
downside of this system, however, is that, while introducing short
restriction enzyme sites is unlikely to interfere with the activity of
cis-regulatory elements or the translation of ORFs, the 25 bp attB
sequences may introduce a bias. As previously found in E. coli,
insect and mammalian cells, we did not detect a decrease in the
translation of proteins translated from ORFs including attB1 or B2
sequences. An interference with the sub-cellular localisation of
tagged proteins is more difficult to detect as addition of N- or
C-terminal tags is known to sometimes interfere with the
localisation of the fusion protein [37]. We note, however, that
using our vectors in Ciona embryos, we could obtain fusion proteins
including translated attB sequences and localising to the
basolateral membranes (Dm-E-Cadherin) [38] , nucleus (Histone
H2), cytoplasm (Venus), and centrosomes (Aurora kinase) as
expected for the fusion protein that was tracked. This suggests that
the few amino acid encoded by attB1/B2 recombination sites do
not significantly interfere with protein localisation.
Figure 9. Chordate expression constructs are suitable for mammalian
cells and zebrafish embryos. A) Transfection in mammalian cells of the
indicated murine enhancers. The Y-axis shows the percentage of
activity (% of LacZ positive cells) of tested Gateway-cloned enhancers
relative to a control CMV-lacZ construct. The left most two columns
were obtained in independent experiments from the other columns,
restricted to Hela cells. B-D) Transient transgenesis by microinjection
into zebrafish eggs of the indicated constructs. Left panel, lateral view,
right panel, dorsal view, of 30 hour post-fertilization stage zebrafish
embryos. No change in the intensity or localisation is observed when
Gateway expression constructs are used (B, D) instead of pCS2+-based
constructs (C). The numbers indicate the proportion of embryos with
the shown lacZ or GFP staining.
doi:10.1371/journal.pone.0000916.g009
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included specific binding sites for transcription factors that could
modify the activity of cloned cis-regulatory regions, we detected no
significant effect in Ciona or zebrafish embryos or tissue culture cells.
Relationships and compatibility with other Gateway
vector systems: from in vivo activity to biochemical
characterisation
When designing the system, we took care to make it compatible
with existing systems. The choice of an attR1-attR2 Gateway
cassette to receive the ORFs was motivated by the fact that most
sequenced Gateway cDNA libraries, as well as C.elegans and
Human ORFeomes were constructed in an attP1-attP2 donor
vector. The choice of the RfA among the available attR1-attR2
cassettes makes our ORF entry clones compatible with these
ORFeomes. In addition, the RfA cassette is also used in the
Proquest Y2H system to look for protein interactors, and in the
Invitrogen bacterial expression vectors. Thus, ORFs characterised
by overexpression in vivo, can be readily transferred into bacterial
or yeast expression vectors that allow further biochemical
characterisation and interaction studies.
Few studies have made use of the multisite Gateway system to
analyse cis-regulatory regions, possibly because the Gateway
system is ideally suited for mid- to large-scale studies and that
few model organisms allow such analyses. In C. elegans, a different
cassette bearing attR4 and attL1 sites was used to build a genome-
wide collection of 59 Gene flanking regions, the promoterome
[14]. This cassette is not compatible with our attR3/R4/R5
cassettes, but, unlike the activity of ORFs [39], the activity of cis-
regulatory sequences is not likely to be conserved between
nematodes and chordates, as conservation between worms and
fly, two protostomes, is already very limited [40].
Opening the way to a systems biology approach to
Ciona development
The recent sequencing of several vertebrate and invertebrate
chordate genomes has widened the gap between the identification
and the functional characterisation of genes. In a majority of cases,
the effects of a gene gain- or loss-of-function in specific tissues is
unknown, as is the subcellular localisation of the gene product, or
identity of the regulatory elements that drive its expression.
Development of the current vector set aimed at facilitating the large
scale unravelling of protein and cis-regulatory sequence activity.
The vector set was initially developed in Ciona intestinalis as this
system provides very fast and efficient means to test within
10 hours the activity of proteins or cis-regulatory regions by
electroporation. Our vector set is suitable to analyse the activity of
the growing collection of publicly available cDNA clones
sequenced from several attR1/R2 Gateway cDNA libraries. This
collection currently covers 60% of the JGI version 1 gene set [41]
and is being extended to generate a full ORF Unigene set in the
frame of a 2006 JGI Community Sequencing project (http://
www.jgi.doe.gov/sequencing/why/CSP2006/seasquirtcDNA.
html). The electroporation vectors described in this article open
the way to large scale gain-of-function screens by electroporation
of small pools of cDNAs under control of a suitable driver,
analogous to those successfully carried out in Xenopus and fish by
the more tedious mRNA injection method. In addition, the
Chordate vector suite allows to add either an N- or C-terminal
Venus-YFP or CyanFP fluorescent protein to any gene product
and thus to track the sub-cellular localisation of proteins of
interest. To validate this strategy, we developed a first set of
fluorescent reporters for different cellular organelles. The current
collection comprises markers to track chromatin (HistoneH2B-
venus), microtubules (Ensconsin), plasma membrane (GAP-43-
GFP), and cytoplasm (Venus) and centrosomes (Aurora Kinase).
These markers should help characterising at the cellular level the
effect of gain or loss of gene function.
Ciona intestinalis is becoming a powerhouse for the characterisa-
tion of cis-regulatory sequences. It has a small compact genome, in
which intergenic and intronic regions are much smaller than in
vertebrates, and phylogenetic footprinting with the sequenced
genome of Ciona savignyi was shown to be an efficient way to
identify cis-regulatory modules. As a result, over 100 ascidian cis-
regulatory sequences have been characterised over the past few
years [42]. Using our novel attR3/R5Gateway cassette and its
derivatives obtained by remobilising one DNA segment, one can
test the activity of sets of full cis-regulatory sequences (L3/L5
cloning into a promoter-less vector), and putative enhancers (L3/
L4 cloning in a vector containing a minimal promoter between the
attB4 and attB5 sites). We validated the vectors on a first set of
regulatory sequences which collectively drive expression through-
out the ectoderm (pFOG), the endoderm (pCi-Titf1), muscle (pCi-
Sna) and notochord (peBra) lineages of early embryos. These entry
clones are part of the current vector suite release (See table page
24 of Manual S1). We are currently extending this collection by
cloning candidate conserved regulatory sequences located in the
vicinity of transcription factor genes.
Towards a comparative functional genomics
approach in chordates
Ciona intestinalis belongs to the tunicates, the closest living relatives
of the vertebrates [4]. This phylogenetic position suggests that
protein localisation and activity may be conserved between Ciona
and vertebrates, a proposal strengthened by our demonstration
that vertebrate Histone, GAP43 and ensconsin fusion proteins
localise to the expected cellular compartment in Ciona cells. The
compatibility of the Human ORFeome entry clones with the
Chordate vector set is thus an encouragement to assay the
subcellular localisation of uncharacterised human proteins in the
simple embryonic context of Ciona. Such studies could be further
extended to the C. elegans ORFeome, thus allowing to test the
evolution of protein function across large evolutionary distances.
While it is expected that protein activity should be largely
conserved within the chordates, the issue of the conservation of the
activity of cis-regulatory sequences is open. In spite of sharing
a common larval body plan, ascidians and vertebrates use very
different embryological strategies, which could have led to a broad
divergence in cis-regulation. Consistent with this, non-coding
sequences conserved within vertebrates cannot be detected in the
Ciona genome [43]. The existence of blocks of sequence conservation
may however not be necessary for the conservation of enhancer
activity [7]. It is at present difficult to estimate the level of
conservation of regulatory logic between ascidians and vertebrates
as there is a single report of a Ciona enhancer been introduced into
vertebrate embryos and in this case the activity was not conserved
[44]. Our demonstration that the chordate vector set is suitable for
the analysis of Ciona, fish and mammalian enhancers is an incentive
to generate collections of enhancers active in each organism and that
can then be tested across the chordate phylum.
MATERIALS AND METHODS
In Vitro Recombination Reactions
The BP reactions were performed in 10 ml with 50 femtomoles of
attB-PCR product, and 50 femtomole of pDonor, 1 ml BP clonase
Chordate Gateway vectors
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femtomole of each plasmid and 1 ml of LR enzyme mix
(Invitrogen) or LR–plus enzyme mix (multisite LR reactions,
Invitrogen). Recombination reactions were incubated for 12h at
room temperature and followed by Proteinase K treatment
(10 min at 37uC) to inactivate the enzyme mix before trans-
formation. Transformation of expression vectors was performed
using 1–2 ml of recombination reaction and 40 ml of electro-
competent DH5a bacteria (efficiency equivalent or higher than
10
8 cfu/mg for multisite Gateway reactions). Transformation of
donor or destination vectors was done using Library Efficiency
DB3.1 chemocompetent cells (Invitrogen).
PCR amplification
All PCR amplifications to built pDest or pEntry clones
were performed with high fidelity DNA polymerase (Pfx,
Invitrogen). Flexi-taq (Promega) was used for routine clone
screening.
Origin of the animals
Ciona intestinalis were obtained from the Roscoff Marine Biology
Station (Roscoff, France). Ascidian gamete collection, fertilisation
and embryo cultures were as in [25]. Zebrafish embryos were
collected from crosses of AB0 and Tu ¨bingen wild type strains kept
under standard conditions.
Electroporations
Plasmid DNA was isolated and purified using Nucleobond PC500
(Macherey Nagel).
The protocol was adapted from a previous report [25] except
that all quantities were halved. Electroporation is performed in
0.4cm cuvettes with a BTX T820 (one pulse, 50V, 16 ms). Under
these conditions, different cells of an embryo inherit different
amounts of plasmid, leading to a mosaic expression of the
transgene.
Injection of mRNAs and plasmids
Microinjections of mRNA in ascidians were carried out as
previously described [25]. All synthetic mRNA were transcribed
with mMachine kit (Ambion). Approximately 30pl of solution at
20 ng/ml were injected per ascidian egg. Fertilized zebrafish eggs
were injected manually at the one cell stage, with injection
solutions containing 1% phenol red and the specified plasmids at
25 ng/ml. Injected embryos were kept at 28uC and collected for
expression analysis at 30 h post fertilization. GFP constructs
injected embryos were analysed live under an epifluorescence
microscope. lacZ construct injected embryos were fixed and X-gal
stained as described previously [45].
Cell transfections
Cell transfections were carried out as previously described [31].
HaCat human keratinocytes and HeLa carcinoma cells were
grown in Dulbecco’s modified Eagle’s medium–10% fetal bovine
serum. Both cell types were transfected using Lipofectamine 2000
(Invitrogen), following the manufacturer’s protocol. Cells were
plated in 60mm dishes and transfected with 4ug of a Gateway
expression construct containing the tk promoter and the various
enhancer regions. To precisely compare the activity of pSP72-B3-
CMV-B5::B1-NLS-LacZ-B2 and pCMV-LacZ (kind gift from R.
Di Lauro), each of these construct was co-electroporated with and
internal control, pCMV-EGFP (Clontech) used to normalize
transfection efficiencies.
X-Gal Staining and immunohistochemistry
X-gal staining was performed as previously described [25]. Anti-
HA immunostaining was performed with a High Affinity Rat
monoclonal antibody (1/200, Roche) incubated overnight at 4uC,
followed by an Alexa 546 conjugated anti-rat antibody (1/500,
Molecular Probe).
Generation of novel pDONR vectors
attP3, attP5, attP4 and attP4R were derived from the attP1 and
attP2 present in pDONR-221 by Overlap Extension PCR
mutagenesis [46] using two perfectly matching primers outside
of the attP, and two primers overlapping by 27 nucleotides and
carrying point mutations in the region of the attPs that confer
recombination specificity (see Table S1 for the sequence of the
primers used).
To generate attP3 from attP1, this strategy leads to a 606bp
fragment flanked by Apa1 and Pst1 restriction sites. This fragment is
used to replace the corresponding attP1 fragment of pDONR-221.
To generate attP4 and attP5 from attP2, the same strategy leads to
a 721bp fragment flanked by EcoR1 and EcoRV, which are used to
replace the corresponding attP2 fragment of pDONR-221. Re-
placement of Apa1-Pst1 flanked attP1 and EcoR1-EcoRV flanked
attP2 sequences by their mutagenised counterparts in pDONR-221
led to pDonor attP3/P5, pDonor attP3/P4. PCR amplification of
attP4 flanked with Apa1 and Pst1 was used to replace attP1 from
pDONR-221-attP1/attP5 and gave rise to pDonor attP4R/P5.
Note that the attP4R is a reverse oriented recombination site of the
attP4, and gives rise to an attR4 site (instead an attL4) in pENTR
clone. All theses pDONRs contain the ccdB and chloramphenicol
resistance genes (Manual S1, page 24).
Construction of the attR3-ccdB-CmR-attR5 cassette
The pFOG regulatory sequence [22] was PCR amplified with the
pFOG attB3-fwd and pFOG-attB5-rev cloned into the EcoRV site
of pBluescriptKS. This plasmid was BP recombined with an attP3-
P5 cassette purified from Apa1 and EcoRV cut pDONR-221-
attP3/P5. After recombination, the resulting pBS-attR3-ccdB-
CmR-attR5 vector was selected on ampicillin and chloramphen-
icol LB agar DB3.1 bacteria. Positive clones were identified by
restriction profile analysis and sequencing.
Construction of the destination vectors
The injection vector pRN3 [27] was modified to give rise to
pSPE3 by inserting a new polylinker EcoR1-Stu1-Pme1-EcoRV-
Not1 (GAATTCAGGCCTTTGTTTAAACTTAGATATCGC-
GGCCGC) between the EcoR1 and Not1 sites. For this, the
two primers pSPE3-Fw and pSPE3-Rev (Table S1) were annealed
and cloned between EcoR1 and Not1.
The electroporation vector pSP72-1.27 [16] was modified to
give rise to pSP72BSSPE by replacing the NLS-LacZ reporter
gene, cloned between BamH1 and EcoR1 by a BamH1-Swa1-
Stu1-Pme1-EcoRV-EcoR1 polylinker (GGATCCATTTAAA-
TAGGCCTTTGTTTAAACTTAGATATCGGAATTC). For
this, the two primers pSP72-Fw and pSP72-Rev (Table S1) were
annealed and cloned between Swa1-EcoRV.
In both vectors, the Reading Frame A cassette (RfA), blunt cut by
EcoRV was subsequently inserted into Pme1. The tag (Venus,
CFP or HA) was amplified by PCR with high fidelity polymerase
(Pfx, Invitrogen), gel purified and inserted by blunt restriction
cloning into Stu1 (N-terminal tags) or EcoRV (C-terminal tags)
(Primers and procedure detailed in Table S2 and Manual S1 page
4). In pSP72BSSPE-RfA vectors, cis-regulatory regions also
amplified by PCR were inserted in Swa1 (Manual S1 page 5).
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R3-R5::B1-ORF-B2 destination vector series, the attR3/R5
cassette was excised by Xho1-Xba1 digestion from pBS-attR3-
ccdB-CmR-attR5 and cloned upstream of the RfA cassette into
the same restrictions sites of pSP72BSSPE-RfA or pSP72BSSPE-
B1-ORF-B2 vectors.
Generation of ORF entry clones
The entry clones (pENTR) containing ORFs or cis-regulatory
region were obtained by recombining an attB-flanked PCR
product and the adequate pDONR vector. The primers used
are presented in Table S3. A Kozak sequence or a stop codon
were added to the the attB1 and attB2 primers when needed to
generate fusion protein constructs as indicated in the Manual S1,
page 11). Depending on individual cases, the attB-flanked PCR
product was generated in one step using long oligonucleotides
containing a region of overlap with the cDNA and the attBs, or in
two steps using shorter overlapping primers. Because of the high
frequency of the self-recombination of pDONR-221-attP4R/P5
resulting in the deletion of the ccdB and CmR genes, a PCR
screen on pENTR-attR4/L5 with M13-fw/M13-rev primers was
systematically applied to bacterial colonies.
ORFs entry clones were amplified (all primers described in
Table S3) from clones previously described. GATAa: (Cieg021-
b07(AK114877), Ci-Aur : GC19c04 (Cieg023k05) both found in
the Ci Gene Collection Release 1 [47]. NLS-lacZ and LacZ : [16].
TauLacZ: [48]. Histone 2B: [49]. Mouse Gap-43-GFP: [19,20].
Venus: [50], Ensconsin-3GFP: [51].
Generation of cis-regulatory region entry clones
The pFOG and pTitf cis-regulatory regions, FOG basal promoter,
eBra and pSna enhancers, were PCR amplified from genomic
DNA using the primers indicated iinn in Table S3.
The viral CMV regulatory region, including enhancer and
promoter, was amplified from pCMV-LacZ using attB3CMV-1
(ATAAAGTAGGCTAGGCCCTTTCGTCTTCACTC) and
attB5CMV-1 (CAAAAGTTGGGTTTAAAAAGTGTTCGAG-
GGGAAA). The mammalian enhancer regions C15, C40 and
C50 were amplified from previously generated tk-Luc containing
plasmids [31], using attB3EnhTK (ATAAAGTAGGCTTAGG-
CTGTCCCCAGTGCAAG) and attB5EnhTK (CAAAAGTT-
GGGTAACAGTACCGGAATGCCAAGC) designed on the
plasmid and tk promoter sequence respectively. Purified PCR
products were further amplified with attB3adapt (GGGGA-
CAAGTTTGTATAATAAAGTAGGCT) and attB5adapt
(GGGGACCACTTTGTATACAAAAGTTGGGT), and recom-
bined into pDONR-221-P3/P5 using BP clonase to obtain the
pENTR clones. The pENTR clones containing the enhancer-tk
sequences were recombined with pSP72BSSPE-R3-ccdB/CmR-
R5::B1-NLS-lacZ-B2.
The zebrafish shh 2.4kb cis-regulatory region was amplified from
the pCS2+-2.4shh:GFP vector with the shh2.4FP-B3 (ATAAAG-
TAGGCT-GTCGACTATTTACTATTTTTT TAGTG) and
shh2.4RP-B5 (ATAAAGTAGGCT-CTCGAGCGGTCTGTC-
TAGCAG) primers. The second round of PCR was performed
with attB3adapt and attB5adapt primers. The purified PCR
product was BP recombined into pDONR-221-P3/P5. The
generated entry clone was sequenced and LR recombined
into pSP72BSSPE-R3-ccdB/CmR-R5::B1-NLS-lacZ-B2, or co-
recombined with pENTR-attL1-Kozak-Venus-Stop-attL2 into
pSP72BSSPE-R3-ccdB/CmR-R5::RfA.
SUPPORTING INFORMATION
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